XNAS
BYRN
Market cap106mUSD
Oct 08, Last price
4.73USD
1D
16.79%
1Q
22.38%
IPO
18.25%
Name
Byrna Technologies Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Byrna Technologies Inc. (BYRN) specializes in less-lethal defense technology, focusing on the creation and manufacturing of non-lethal munitions and associated security equipment. The company's primary offerings include a line of Byrna-branded handheld personal protection instruments, such as the Byrna SD and Byrna SD .68 caliber models, which are specifically designed for both civilians and private security professionals. Complementing these devices, Byrna also provides related products like Byrna HD magazines, shoulder-fired launchers, and various projectiles. Its comprehensive catalog further extends to a range of accessories and safety gear, notably the Byrna Banshee, Byrna Shield, compressed carbon dioxide cartridges, aiming systems, holsters, and branded apparel. Incorporated in 2005 and headquartered in Andover, Massachusetts, the firm conducts its business in the United States and South Africa. It previously operated as Security Devices International, Inc., changing its name to Byrna Technologies Inc. in March 2020.
Key people
Jim Dunfey
Chief Accounting Officer · since 2019
Lisa Klein Wager
General Counsel, Chief Legal Officer, Corporate Secretary · since 2019
Director · since 2014
Bryan Scott Ganz
Chairman of the Board, President, Chief Executive Officer · since 2019
Paul Jensen
Director · since 2019
David Goodbrand
Independent Director · since 2012
Herbert Hughes
Independent Director · since 2019
Karim Kanji
Independent Director · since 2014
Beatrice Mitchell
Independent Director · since 2019
Independent Director · since 2014
William B. Richards
Independent Director · since 2019
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑11 | 2024‑11 | 2023‑11 | 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||